Review of bioequivalence studies of cholecalciferol drugs
Introduction: The general requirements for assessing bioequivalence of endogenous drugs are described in the relevant guidelines, but they do not provide a complete picture of how to adequately develop a design of such a study. The aim of this article is to offer recommendations on the development o...
Saved in:
Main Authors: | Alexander L. Khokhlov (Author), Dmitry P. Romodanovsky (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The ability to predict the results of bioequivalence studies based on a consistent statistical analysis of informative factors
by: Dmitry P Romodanovsky, et al.
Published: (2020) -
Problems of bioanalytical part of bioequivalence studies of drugs in Russia
by: A. L. Khokhlov, et al.
Published: (2014) -
Analysis of the quality of bioequivalence and pharmacokinetics studies in Russia Federation
by: A. L. Khokhlov, et al.
Published: (2018) -
Cholecalciferol level and its impact on COVID-19 patients
by: Mohammed Abdel Monem Saeed, et al.
Published: (2022) -
Immunomodulatory properties of cholecalciferol in rats with experimentally induced inflammation
by: Nina Doncheva, et al.
Published: (2024)